Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT).
about
Usefulness of the MRP2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP1B1Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).
P2860
Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Enhanced antitumour drug deliv ...... bile acid transporter (ASBT).
@en
type
label
Enhanced antitumour drug deliv ...... bile acid transporter (ASBT).
@en
prefLabel
Enhanced antitumour drug deliv ...... bile acid transporter (ASBT).
@en
P50
P1476
Enhanced antitumour drug deliv ...... bile acid transporter (ASBT).
@en
P2093
Elisa Lozano
Oscar Briz
P304
P356
10.1016/J.JCONREL.2015.08.022
P407
P577
2015-08-13T00:00:00Z